Company intelligence / Profile preview

Medicox

Gangnam-gu, Seoul, South Koreadacon.io ↗

Ownership: Private
Employees: ~28
Development stage: Other

Overview

Medicox primarily operates as a healthcare/pharmaceuticals distributor in South Korea. It also manufactures specialized shipbuilding components. Through its investment in Mecox CureMed, it has exposure to early-stage drug development for COVID‑19 treatments and anticancer drugs using natural substances. No clinical results are directly attributed to Medicox itself.

Industry: Non-Academic Healthcare

Partnerships

Major clients include Hyundai Heavy IndustriesHyosung Heavy IndustriesHyundai Rotem in the shipbuilding/equipment sector

Beyond the preview

Go deeper on Medicox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicox.

Explore the full profile